Last Updated: September 24, 2026

Patent: 10,246,522

✉ Email this page to a colleague

Summary for Patent: 10,246,522

Title:	Cellulose particulate material
Abstract:	The invention relates to plant-derived cellulose-containing particles useful as strengthening agents in water based systems and to a process for preparing cellulose-containing particles from plant material, which process involves treating said plant material with a peroxide reagent. The process can be controlled to produce cellulose-containing particle having a viscosity up to about 2500 cps.
Inventor(s):	David Hepworth, Eric Whale
Assignee:	Cellucomp Ltd
Application Number:	US14/778,368
Patent Claims:	see list of patent claims

Details for Patent 10,246,522

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	SIMPONI	golimumab	Injection	125289	24-Apr-09	⤷ Start Trial	2034-03-18
Janssen Biotech, Inc.	SIMPONI	golimumab	Injection	125289	15-May-13	⤷ Start Trial	2034-03-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,246,522

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Brazil	112015023876	⤷ Start Trial
Brazil	112015023908	⤷ Start Trial
Canada	2941817	⤷ Start Trial
Canada	2941925	⤷ Start Trial
China	105209521	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.